RiverFront Investment Group LLC Has $896,000 Holdings in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)

RiverFront Investment Group LLC cut its holdings in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) by 5.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 38,919 shares of the company’s stock after selling 2,127 shares during the period. RiverFront Investment Group LLC’s holdings in iShares Genomics Immunology and Healthcare ETF were worth $896,000 as of its most recent filing with the SEC.

iShares Genomics Immunology and Healthcare ETF Stock Performance

Shares of IDNA stock traded up $0.36 on Friday, hitting $22.30. The company’s stock had a trading volume of 17,775 shares, compared to its average volume of 41,240. The stock’s 50 day moving average is $23.52 and its 200-day moving average is $22.00. iShares Genomics Immunology and Healthcare ETF has a fifty-two week low of $17.33 and a fifty-two week high of $25.52. The company has a market capitalization of $130.46 million, a PE ratio of 2.12 and a beta of 1.06.

iShares Genomics Immunology and Healthcare ETF Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.